EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Editor's Choice – VASCUNET Rare Vascular Diseases: Multicentre Genetic Investigation of Patients with Carotid Paraganglioma

Philipp Erhart, Tina Cohnert, Gregor K Siegl, Suzana Anjum, Imke Matthys, Silvia Romagnoli, Cristina López Espada, Maria-Dolores Chiara, Alicja Szatko, Christian-Alexander Behrendt, Stefano Ancetti, VASCUNET Committee of the European Society for Vascular Surgery

European Journal of Vascular and Endovascular Surgery · 2025

DOI: 10.1016/j.ejvs.2025.07.013 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2025. Verfasst von Philipp Erhart und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Endovascular Surgery, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: philipp.erhart@med.uni-heid…. Hauptthemen laut MEDLINE: Carotid Body Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heidelberg Foundation for Surgery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Carotid paragangliomas (CPGLs) are rare neuroendocrine tumours. Previous studies have emphasised the high prevalence of hereditary genetic variants. This study specifically examined the clinical course of CPGLs in patients with pathogenic disease causing genetic variants (PV) and non-specific non-pathogenic genetic findings (non-PV) currently not associated with CPGLs. METHODS: This was a multicentre, retrospective, exploratory study. Whole genome, exome, or gene panel sequencing was performed in participating centres in the clinical diagnostic setting. Genetic variants were described following appropriate reporting standards. Re-evaluation regarding their pathogenicity was performed according to the American College of Medical Genetics and Genomics guidelines. Individuals with benign, probably benign, or variants of unknown significance were assigned to the non-PV group, and individuals with probably pathogenic or pathogenic variants were assigned to the PV group. Relevant clinical variables and follow up data were collected to relate clinical outcomes to genetic findings. RESULTS: One hundred and seventy-three patients were analysed, of whom 45.1% had PVs in respective candidate genes for paraganglioma, including the succinate dehydrogenase (SDH) complex subunit D (n = 56), B (n = 17), C (n = 3), A (n = 1) and von Hippel-Lindau (n = 1) genes. Those with PVs were younger (median age 44 years vs. 60 years; p< .001), had a greater likelihood of multilocular paraganglioma manifestation (47 vs. 2; p< .001), and more frequently had local recurrences after surgical removal (20 vs. 1; p< .001). Tumour recurrence occurred a mean of 8.5 years following surgery. Bilateral CPGLs (39 vs. 2; p< .001) and a positive familial history of paraganglioma (28 vs. 4; p< .001) were associated with PVs. CONCLUSION: Genetic variants, especially in the SDHD gene, were common and associated with worse CPGL outcomes, thus emphasising the benefit of genetic diagnostics and counselling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carotid Body TumorHumansFemaleMiddle AgedMaleRetrospective StudiesAdultAgedSuccinate DehydrogenaseGenetic Predisposition to DiseaseGenetic Testing

Stichwörter der Autor:innen

Carotid paragangliomaGeneticsHead and neck tumourRare disease registerSDH mutationVascular tumour

Substanzen

Succinate DehydrogenaseSDHD protein, human

Autor:innen und Institutionen

  • Department of Vascular and Endovascular Surgery, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: philipp.erhart@med.uni-heidelberg.de.
  • Department of Vascular Surgery, Medical University of Graz, Graz, Austria.
  • Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
  • Department of Endocrinology, Ghent University Hospital, Ghent, Belgium.
  • Section of Vascular Surgery, Department of Cardiac, Thoracic and Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Vascular Surgery Unit, University Hospital Virgen de las Nieves, Granada, Spain.

Förderung

  • Heidelberg Foundation for Surgery

Zitieren

APA

Erhart, P., Cohnert, T., Siegl, G. K., Anjum, S., Matthys, I., Romagnoli, S., Espada, C. L., Chiara, M. D., Szatko, A., Behrendt, C. A., Ancetti, S., & VASCUNET Committee of the European Society for Vascular Surgery (2025). Editor's Choice – VASCUNET Rare Vascular Diseases: Multicentre Genetic Investigation of Patients with Carotid Paraganglioma. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2025.07.013

Vancouver

Erhart P, Cohnert T, Siegl GK, Anjum S, Matthys I, Romagnoli S, et al. Editor's Choice – VASCUNET Rare Vascular Diseases: Multicentre Genetic Investigation of Patients with Carotid Paraganglioma. European Journal of Vascular and Endovascular Surgery. 2025. doi:10.1016/j.ejvs.2025.07.013

BibTeX
@article{Erhart2025,
  author = {Erhart, Philipp and Cohnert, Tina and Siegl, Gregor K and Anjum, Suzana and Matthys, Imke and Romagnoli, Silvia and Espada, Cristina López and Chiara, Maria-Dolores and Szatko, Alicja and Behrendt, Christian-Alexander and Ancetti, Stefano and VASCUNET Committee of the European Society for Vascular Surgery, VASCUNET Committee of the European Society for Vascular Surgery},
  title = {Editor's Choice – VASCUNET Rare Vascular Diseases: Multicentre Genetic Investigation of Patients with Carotid Paraganglioma},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2025},
  doi = {10.1016/j.ejvs.2025.07.013}
}
Kostenlos starten →